SOLACI-SOCIME 2022 | Mitral valve replacement

Read the most outstanding articles from the first day of the SOLACI-SOCIME 2022 Congress.

In this case, consult the presentation by Dr. Ignacio Amat Santos, entitled “Mitral valve replacement”

amat-santos-tmvr


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

SOLACI-SOCIME 2022 | Big Necks, (PEVAR IN HOSTILE NECK) – Dr. Juan Varela

Veja esta apresentação do Dr. Juan Varela (COL) durante o Congresso SOLACI-SOCIME 2022 realizado na Expo Santa Fé, CDMX nos dias 4, 5 e...

SOLACI-SOCIME 2022 | Advances in the design of STENTS in PCI: DIABETES MELLITUS – Dr. Roxana Mehran

Enjoy this master conference given by Dr. Roxana Mehran during the SOLACI-SOCIME 2022 Congress held at Expo Santa Fé, CDMX on August 4, 5...

SOLACI-SOCIME 2022 | Management of entrapped equipment, by Dr. José Velazco

Read the most outstanding articles from the first day of the SOLACI-SOCIME 2022 Congress. In this case, consult the presentation by Dr. José Velazco, entitled...

SOLACI-SOCIME 2022 | Transcatheter treatment of mitral valve regurgitation, by Dr. Luis Nombela Franco

Read the most outstanding articles from the first day of the SOLACI-SOCIME 2022 Congress. In this case, consult the presentation by Dr. Luis Nombela Franco,...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

COILSEAL: Use of Coils in Percutaneous Coronary Intervention, Useful for Complication Management?

The use of coils as vascular closing tool has been steadily expanding beyond its traditional role in neuroradiology into coronary territory, where it remains...

Treatment of In-Stent Restenosis in Small Vessels with Paclitaxel-Coated Balloons

Coronary artery disease (CAD) in smaller epicardial vessels occurs in 30% to 67% of patients undergoing percutaneous coronary intervention and poses particular technical challenges....

Contemporary Challenges in Left Atrial Appendage Closure: Updated Approach to Device Embolization

Even though percutaneous left atrial appendage (LAA) closure is generally safe, device embolization – with 0 to 1.5% global incidence – is still a...